CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 51 enrolled
Drug / intervention
Lubricant Eye Drops (Optive™) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00756678
NCT00756678Phase 4Completed
CompareCT.gov

Efficacy and Acceptability of Two Lubricant Eye Drops

Allergan·interventional·Posted Sep 22, 2008·Updated Oct 31, 2011

In Brief

A Phase 4 clinical trial evaluating Lubricant Eye Drops (Optive™) and Lubricating Eye Drops (blink® Tears) for Dry Eye Syndromes. Completed, enrolled 51 participants across 1 site.

Detailed Summary

Efficacy and acceptability of two new artificial tears following two weeks of treatment in patients with dry eye. Patients will be randomized to 1 of 2 treatments for 7 days then crossover to the alternate treatment for 7 days.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye Syndromes
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 22, 2008
Enrollment StartSep 1, 2008
Primary CompletionAug 1, 2009
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 17.8 years ago

Interventions

Lubricant Eye Drops (Optive™)drug

1 drop in both eyes as needed for 7 days'

Lubricating Eye Drops (blink® Tears)drug

1 drop in both eyes as needed for 7 days